SurModics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch SurModics and buy or sell other stocks, ETFs, and their options commission-free!About SRDX
Surmodics, Inc. engages in the provision of surface modification technologies for intravascular medical devices, and chemical and biological components for in vitro diagnostic immunoassay tests and microarrays. It also develops and commercializes medical devices that are designed to address unmet clinical needs and engineered to the most demanding requirements.
CEOChip Hance, MBA
CEOChip Hance, MBA
Employees—
Employees—
HeadquartersEden Prairie, Minnesota
HeadquartersEden Prairie, Minnesota
Founded1979
Founded1979
Employees—
Employees—
SRDX Key Statistics
Market cap614.53M
Market cap614.53M
Price-Earnings ratio-34.75
Price-Earnings ratio-34.75
Dividend yield—
Dividend yield—
Average volume1.60M
Average volume1.60M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$43.00
52 Week high$43.00
52 Week low$25.87
52 Week low$25.87
Stock Snapshot
The current SurModics(SRDX) stock price is $42.98, with a market capitalization of 614.53M. The stock trades at a price-to-earnings (P/E) ratio of -34.75.
SurModics(SRDX) stock opened on 2026-01-07 at —. The price climbed to — and dipped to —.
The SurModics(SRDX)'s current trading volume is 0, compared to an average daily volume of 1.6M.
In the last year, SurModics(SRDX) shares hit a 52-week high of $43.00 and a 52-week low of $25.87.
In the last year, SurModics(SRDX) shares hit a 52-week high of $43.00 and a 52-week low of $25.87.
People also own
Based on the portfolios of people who own SRDX. This list is generated using Robinhood data, and it’s not a recommendation.